https://www.selleckchem.com/pr....oducts/Novobiocin-so
, with MICs in the range of 0.007-2µg/mL, better than linezolid, the only clinically used agent available to date. Such results reinforce the rationale of considering existing and newly designed CAIs as antibacterials with an alternative mechanism of action. Balancing the equilibrium between CO2 and HCO3- is essential for microbial metabolism and is regulated by at least four classes of CAs. Classical CA inhibitors (CAIs) such as ethoxzolamide were shown to kill the gastric pathogen Helicobacter pylori in vitro, whe
Like
Comment
Share
